QRVO vs RNAC · P/E 27, rev $3.68B vs P/E 2.1, rev $78.0K
Qorvo Inc (QRVO) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Latest reported RNAC revenue for 2026-06-30 was $78.0K. Net income was -$23.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
QRVO currently screens at market cap $8.54B and trailing P/E 26.8. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the QRVO and RNAC stock pages for the full models.
Not investment advice.